COMPANION ANIMAL ARTHRITIS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2023 - 2030)

Osteoarthritis (OA) is a common condition that affects dogs and cats. It is characterized as a low-grade inflammatory, progressive degenerative joint disease. OA results from degeneration and aberrant repair of articular cartilage in association with alterations in subchondral bone metabolism, osteophytosis, and synovial inflammation. In companion animals, OA is almost always secondary to an underlying abnormality, such as joint laxity, osteochondrosis, trauma, etc. It is a pathological process that includes joint capsule fibrosis and periosteal reactions, leading to an altered gait and range of motion. In turn, there is a deterioration of the musculoskeletal system and secondary joint stabilizers, resulting in further deterioration of articular cartilage due to abnormal loading and wear.

Market Dynamics:

The global companion animal arthritis market is mainly driven by the increasing development of novel therapeutics. For instance, the Canadian Institutes of Health Research (CIHR) funded a US$600,000 Computer-aided design (CAD) project launched in 2021 focused on evaluating the efficacy of mesenchymal stem cells for the treatment of osteoarthritis in dogs. The study involves a randomized, double-blinded, placebo-controlled clinical trial involving client-owned dogs with elbow or stifle osteoarthritis (source: CIHR project funding). Findings from these studies will provide valuable insights into the potential of new regenerative medicine options. Furthermore, the greater availability of advanced treatment choices will encourage more pet owners to actively manage their pet's arthritis with the help of veterinarians. This, in turn, will fuel ongoing expansion in the companion animal arthritis market beyond the foreseeable future.

Key features of the study:

• This report provides in-depth analysis of the global companion animal arthritis market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2023–2030), considering 2022 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends,  regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global companion animal arthritis market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Vetoquinol, NexGen Pharmaceuticals, Norbrook, Eltech K-Laser s.r.l, Zoetis, Virbac, Elanco, Boehringer Ingelheim International GmbH, Ceva, Dechra Pharmaceuticals PLC .
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global companion animal arthritis market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global companion animal arthritis market

Global Companion animal arthritis Market Detailed Segmentation:

• By Animal Type
  • Dogs
  • Cats
  • Others
• By Indication
  • Osteoarthritis
  • Other Arthritis
• By Treatment
  • Medication
    • NSAIDs
    • Monoclonal Antibodies
    • Others Medications
  • Supplements
  • Other Treatment
• By Distribution Channel
  • Veterinary Hospitals & Clinics
  • Retail Pharmacies
  • Online Stores
  • Others
• By Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Global Companion animal arthritis Market, Key Players
  • Vetoquinol
  • NexGen Pharmaceuticals
  • Norbrook
  • Eltech K-Laser s.r.l
  • Zoetis
  • Virbac
  • Elanco
  • Boehringer Ingelheim International GmbH
  • Ceva
  • Dechra Pharmaceuticals PLC
  • Others Prominent Players .